Hong Hoi Ting

Early Phase I Study of a ^99mTc-Labeled Anti–Programmed Death Ligand-1 (PD-L1) Single-Domain Antibody in SPECT/CT Assessment of PD-L1 Expression in Non–Small Cell Lung Cancer

Yan Xing, Gitasha Chand, Changchun Liu et al. · Journal of Nuclear Medicine · 2019 · 166 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

Molecular identity of a pan cancer marker, CA215

Gregory Lee, Emily Laflamme, Chin-Hsiang Chien et al. · Cancer Biology & Therapy · 2008 · 71 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

Preclinical assessment of anti-cancer drugs by using RP215 monoclonal antibody

Gregory Lee, Ruiai Chu, Hong Hoi Ting · Cancer Biology & Therapy · 2009 · 40 citations · Full text

Medicine, Oncology, Pharmacology +17

Preclinical development and characterisation of ^99mTc-NM-01 for SPECT/CT imaging of human PD-L1.

Nicholas C.L. Wong, Yina Cai, Levente K. Meszaros et al. · PubMed · 2021 · 11 citations · Full text

Medicine, Nuclear Medicine, Radiology +13